Trial Profile
Proof of concept study of thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Aug 2015
Price :
$35
*
At a glance
- Drugs Thrombomodulin alfa (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Pharmacodynamics; Proof of concept
- 31 Aug 2015 New trial record